Biogaia

Biogaia P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Biogaia (BIOG B.ST) as of Nov 11, 2026 is 34.57. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 28.40 — a change of 21.74% (higher).

P/CF

34.57

YoY

21.74%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Biogaia is 2025 34.57 . P/CF (Price-to-Cash-Flow Ratio) of Biogaia was 2024 28.40 . It decreases by 21.74% higher compared to the previous year.

The Biogaia P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
57.88 SEK
Jan 1, 2019
71.68 SEK
Jan 1, 2020
47.90 SEK
Jan 1, 2021
47.77 SEK
Jan 1, 2022
33.23 SEK
Jan 1, 2023
24.88 SEK
Jan 1, 2024
28.40 SEK
Jan 1, 2025
34.57 SEK
The Biogaia P/CF history
YEARP/CFYoY
34.57+21.74%
28.40+14.13%
24.88-25.12%
33.23-30.43%
47.77-0.28%
47.90-33.17%
71.68+23.85%
57.88+21.57%
47.61-33.55%
71.64-20.57%
90.20+5.86%
85.21—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

P/CF (Price-to-Cash-Flow Ratio) of Biogaia is 34.57 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Biogaia changed from 28.40 to 34.57, representing a 21.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Biogaia since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Biogaia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Biogaia

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Biogaia